These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 7867870)
21. Influence of dietary composition on the inhibition of fat absorption by orlistat. Güzelhan C; Odink J; Niestijl Jansen-Zuidema JJ; Hartmann D J Int Med Res; 1994; 22(5):255-65. PubMed ID: 7867870 [TBL] [Abstract][Full Text] [Related]
22. Mode of action of orlistat. Guerciolini R Int J Obes Relat Metab Disord; 1997 Jun; 21 Suppl 3():S12-23. PubMed ID: 9225172 [TBL] [Abstract][Full Text] [Related]
23. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. Zhi J; Melia AT; Eggers H; Joly R; Patel IH J Clin Pharmacol; 1995 Nov; 35(11):1103-8. PubMed ID: 8626884 [TBL] [Abstract][Full Text] [Related]
24. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Hauptman JB; Jeunet FS; Hartmann D Am J Clin Nutr; 1992 Jan; 55(1 Suppl):309S-313S. PubMed ID: 1728845 [TBL] [Abstract][Full Text] [Related]
25. [Inhibitors of absorption as anti-obesity drugs]. Tsuji M; Saito N; Inoue S Nihon Yakurigaku Zasshi; 2001 Nov; 118(5):340-6. PubMed ID: 11729638 [TBL] [Abstract][Full Text] [Related]